NCT01938729View on ClinicalTrials.gov

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 5, 2013

Primary Completion Date

September 10, 2020

Study Completion Date

September 10, 2020

Conditions
Intrahepatic CholangiocarcinomaPeripheral CholangiocarcinomaCholangiolar CarcinomaCholangiocellular Carcinoma) (ICC)
Interventions
PROCEDURE

Liver resection and placement of hepatic artery infusion pump

DRUG

FLOXURIDINE

DRUG

DEXAMETHASONE

DRUG

GEMCITABINE

Trial Locations (5)

10065

Memorial Sloan Kettering Cancer Center, New York

10591

Memorial Sloan Kettering Cancer Center Sleepy Hollow, Sleepy Hollow

11570

Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre

11725

Memorial Sloan Kettering Cancer Center at Commack, Commack

Unknown

Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge

All Listed Sponsors
collaborator

Ohio State University

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

Washington University School of Medicine

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01938729 - Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma | Biotech Hunter | Biotech Hunter